Ultragenyx Analyst & Investor Day
December 4, 2017
Ultragenyx management will review development progress and commercial readiness, and outside experts will share their perspectives.
Ultragenyx Pharmaceutical, Inc. [RARE] US$3,255 MM MCap
Biotechnology company based in Novato, CA founded by the former CMO of BioMarin. The company is focusing on developing protein or small molecule therapies for rare genetic disorders. Ultragenyx will choose product candidates with clear biology and diseases with high unmet medical need and apply , and rapid and efficient development strategies. . [more information]